RxDoctor Payments Data

Ellen McBride, MD

Psychiatry · Reno, NVNPI 1790845519

Payments from drug & device makers

$540in general payments, 2019–2025

Across 27 payments — averaging $20.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$187
  • Johnson & Johnson$90
  • Lundbeck LLC$66
  • Neuronetics, Inc.$54
  • Vanda Pharmaceuticals Inc.$42
  • Sunovion Pharmaceuticals Inc.$39
  • plus $62 from 3 others

What the payments were for

  • Food & beverage$540100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$540 in reported general payments places this provider in the 50th percentile of 243 psychiatry providers in Nevada.

See all psychiatry providers in Nevada

Medicare billing

Part B allowed, 2024
$97,967
Medicare patients
156
Services billed
913

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate11$92,619
VraylarCariprazine Hcl23$52,272
RexultiBrexpiprazole15$35,232
Invega SustennaPaliperidone Palmitate11$24,413
TrintellixVortioxetine Hydrobromide19$12,902
Aripiprazole176$10,843
Quetiapine Fumarate347$6,253
Quetiapine Fumarate ErQuetiapine Fumarate45$4,710
Vilazodone Hcl42$4,301
Lamotrigine ErLamotrigine14$3,713
Duloxetine Hcl178$3,405
Mirtazapine92$3,362
Venlafaxine Hcl ErVenlafaxine Hcl158$3,298
Bupropion XlBupropion Hcl101$3,184
Divalproex Sodium20$3,046

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$15$92,61911 claims
AbbVieVraylar$187$52,27223 claims
Otsuka America Pharmaceutical, Inc.Rexulti$36$35,23215 claims
Johnson & JohnsonInvega Sustenna$90$24,41311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 243 psychiatry providers in Nevada.

Other psychiatry in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →